Skip to main content
. 2022 Jun 13;28(16):3452–3463. doi: 10.1158/1078-0432.CCR-21-4020

Figure 4.

Figure 4. Time on study for patients according to tumor type in (A) dose-escalation and dose-expansion part I cohorts, and (B) dose-expansion part II cohorts.

Time on study for patients according to tumor type in (A) dose-escalation and dose-expansion part I cohorts, and (B) dose-expansion part II cohorts.